mFolfirinox-Panitumumab Regimen

Preferred Label : mFolfirinox-Panitumumab Regimen;

NCIt synonyms : mFolfirinox Plus Panitumumab; mFolfirinox-Vectibix; mFolfirinox/Panitumumab; mFolfirinox/Panitumumab Regimen; mFolfirinox-Panitumumab; Panitumumab-mFolfirinox; Modified Folfirinox-Panitumumab Regimen; Panitumumab Plus mFOLFIRINOX Regimen;

NCIt definition : A modified, dose-adjusted regimen consisting of fluorouracil, leucovorin, oxaliplatin and irinotecan (mFOLFIRINOX), plus panitumumab that may be used in the treatment of certain types of colon and rectal cancers.;

NCI Metathesaurus CUI : CL1794483;

Détails

Origin ID

C189335;

UMLS CUI

C5708382;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Fluorouracil [NCIt concept]
- Irinotecan Hydrochloride [NCIt concept]
- Leucovorin Calcium [NCIt concept]
- Oxaliplatin [NCIt concept]
- Panitumumab [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients